Cargando…
COX-2 Inhibitor Use as an Early Treatment Option for Knee Osteoarthritis Patients in Korea: A Population-Based Cross-Sectional Study
BACKGROUND: To investigate the use of cyclooxygenase-2 (COX-2) inhibitors as an initial drug treatment for knee osteoarthritis (OA) patients. METHODS: From 2013 to 2015, patients with knee OA were identified from the Korean nationwide claims database. Among them, we extracted incident cases of knee...
Autores principales: | Cho, Soo-Kyung, Choi, Seongmi, Kim, Hyoungyoung, Song, Yeo-Jin, Jung, Sun-Young, Jang, Eun Jin, Sung, Yoon-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091425/ https://www.ncbi.nlm.nih.gov/pubmed/35535375 http://dx.doi.org/10.3346/jkms.2022.37.e148 |
Ejemplares similares
-
Factors related to the use of opioids as early treatment in patients with knee osteoarthritis
por: Cho, Soo-Kyung, et al.
Publicado: (2019) -
Impact of Osteoarthritis on Household Catastrophic Health Expenditures in Korea
por: Kim, Hyoungyoung, et al.
Publicado: (2018) -
Treatment patterns of knee osteoarthritis patients in Korea
por: Park, Ha-Rim, et al.
Publicado: (2019) -
Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world
por: Sung, Yoon-Kyoung, et al.
Publicado: (2020) -
Comparison of healthcare resource utilization and medical costs between patients with seropositive and seronegative rheumatoid arthritis
por: Kim, Hyoungyoung, et al.
Publicado: (2021)